Yoga and Aerobic Exercise in Epilepsy
NCT05066880, Not applicable, Completed, Dokuz Eylul University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Yoga and Aerobic Exercise in Epilepsy | ClinicalTrials.gov |
| NCT number | NCT05066880 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 60 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Dokuz Eylul University | ClinicalTrials.gov |
| Conditions | Epilepsy, Epilepsy; Seizure, Epilepsy Idiopathic | ClinicalTrials.gov |
| Interventions | Exercise training | ClinicalTrials.gov |
| First posted | 2021-10-04 | ClinicalTrials.gov |
| Last updated | 2024-05-16 | ClinicalTrials.gov |
Registered outcomes 18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Physical activity in daily life | change from baseline to 8 weeks | Physical activity will be objectively monitored with an accelerometer. | ClinicalTrials.gov |
| Primary | Seizure | change from baseline to 8 weeks | Participants will be given a seizure diary and requested to record the number of their seizure. | ClinicalTrials.gov |
| Secondary | Six-Minute Walk test | change from baseline to 8 weeks | The Six-Minute Walk test will be used to determine functional capacity. | ClinicalTrials.gov |
| Secondary | 30-second Chair Stand test | change from baseline to 8 weeks | Lower body strength will be determined using the 30-second Chair Stand test. | ClinicalTrials.gov |
| Secondary | Biodex Balance System | change from baseline to 8 weeks | Balance evaluation will be performed with Biodex Balance System. | ClinicalTrials.gov |
| Secondary | Bioelectrical impedance analyzer | change from baseline to 8 weeks | Body composition measurements will be performed with bioelectrical impedance analyzer. | ClinicalTrials.gov |
| Secondary | Waist and hip circumference | change from baseline to 8 weeks | For the anthropometric measurements, waist and hip circumference will be taken. | ClinicalTrials.gov |
| Secondary | Trail Making test and Digit Span test | change from baseline to 8 weeks | The Trail Making test and Digit Span test will be used to evaluate for attention. | ClinicalTrials.gov |
| Secondary | Stroop test and Verbal Fluency | change from baseline to 8 weeks | The Stroop test and Verbal Fluency will be used to evaluate for executive functions. | ClinicalTrials.gov |
| Secondary | Weschler Memory Scale-Revised Visual Reproduction subtest | change from baseline to 8 weeks | The Weschler Memory Scale-Revised Visual Reproduction subtest will be used to evaluate for visual memory. | ClinicalTrials.gov |
| Secondary | Clock Drawing test | change from baseline to 8 weeks | The Clock Drawing test will be used to evaluate for visual perception and visual-spatial functions. | ClinicalTrials.gov |
| Secondary | Oktem Verbal Memory Processes test | change from baseline to 8 weeks | The Oktem Verbal Memory Processes test will be used to evaluate for verbal memory performance. | ClinicalTrials.gov |
| Secondary | Neurological Disorders Depression Inventory for Epilepsy | change from baseline to 8 weeks | The Neurological Disorders Depression Inventory for Epilepsy will be used to evaluate for depression. | ClinicalTrials.gov |
| Secondary | Generalized Anxiety Disorder-7 | change from baseline to 8 weeks | Anxiety will be determined by the Generalized Anxiety Disorder-7. | ClinicalTrials.gov |
| Secondary | 10-item Perceived Stress Scale | change from baseline to 8 weeks | The 10-item Perceived Stress Scale will be used to assess subjective stress. | ClinicalTrials.gov |
| Secondary | Fatigue Impact Scale | change from baseline to 8 weeks | Fatigue will be assessed with the Fatigue Impact Scale. | ClinicalTrials.gov |
| Secondary | Pittsburg Sleep Quality Index | change from baseline to 8 weeks | Sleep quality will be measured using the Pittsburg Sleep Quality Index. | ClinicalTrials.gov |
| Secondary | Quality of Life in Epilepsy Inventory-31 | change from baseline to 8 weeks | It will be used to determine health-related quality of life for epilepsy. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 37151132 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 6
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Clock Drawing Task | Secondary outcome | ConductCognition |
| Digit Span Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
| Verbal Fluency | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)